Industry news

• Global neoantigen cancer vaccine market will grow exponentially

  17 January 2020 GMP News

  A new report suggests that the neoantigen cancer vaccine market will grow at a compound annual growth rate (CAGR) of 34.69 percent during the forecast period, 2023-2030.

• Move me: Emotional appeals motivate doctors more than facts and figures do

  17 January 2020 Beth Snyder Bulik / FiercePharma

  When it comes to marketing, doctors aren’t the rational robots one might assume. A new study from Wunderman Thompson Health found physicians are much more likely to respond to emotional appeals over regurgitated data points in advertising.

• Science towns in the Moscow region will receive more than 338 M rubles in 2020

  17 January 2020 GMP News

  At the end of December 2019, the Ministry of Science and Higher Education of the Russian Federation and the Moscow Region Government signed an agreement on allocating in 2020 a subsidy from the federal budget to the Moscow Region budget in order to implement strategies for the socio economic development of the science towns of the Russian Federation.

• Research hospital jumping into commercial production of gene therapies

  16 January 2020 Eric Palmer / FiercePharma

  A new commercial-scale gene therapy manufacturing facility is being planned, but not by a biotech or even a CDMO. This one will be built by a hospital in Columbus, Ohio. 

• First edition of the EAEU Pharmacopoeia completed

  16 January 2020 GMP News

  The Eurasian Economic Commission (EEC) has completed scientific and technical editing of 157 draft general pharmacopoeia monographs included in the first edition of the Eurasian Economic Union (EAEU) Pharmacopoeia. On December 27, these drafts were approved by Elena Sakanyan, Chairman of the Pharmacopoeia Committee of the Eurasian Economic Union. In the near future, the issue on approving the EAEU Pharmacopoeia is planned to be submitted to a meeting of the Commission’s Board.

• Milestones of the Russian labeling system

  15 January 2020 GMP News

  The Russian Government has established the particularities of implementing a system of digital labelling and tracking of medicinal products. Taking into account the successful launch of the labeling of the drugs that took part in the Seven Nosologies Program from October 1, 2019, the Russian Government signed the Proposition No. 1954 of December 31, 2019. This document defines the optimal regime to prepare all participants of the drug product circulation for the date of mandatory labelling of all drugs. The Resolution shall come into force on the date of its publication.

• Education and strategy are key to nurturing biosimilars for success

  15 January 2020 FiercePharma

  Heralded as the next great chapter in pharmaceutical history, biosimilars are expected to trim healthcare costs while giving patients more access at lower prices. Adopted with open arms in the European market, the move to biosimilars in the U.S. has been a slog.

• More control over the antibiotics in the Russian agricultural sector

  14 January 2020 GMP News

  “Federal Service for Veterinary and Phytosanitary Surveillance (FSVPS) has developed and sent to the Ministry of Agriculture a package of amendments to the law ‘On Veterinary Medicine’, which regulates the use of antibiotics in livestock and poultry farming,” said Sergey Dankvert, the head of the department.

• Announced the launch of the Unified Website for Biotechnology Regulation

  14 January 2020 GMP News

  The U.S. Food and Drug Administration, the Department of Agriculture and the Environmental Protection Agency launched a Unified Website for Biotechnology Regulation. The website streamlines information about the three regulatory agencies charged with overseeing agriculture biotechnology products and is part of President Donald J. Trump’s Executive Order on Modernizing the Regulatory Framework for Agricultural Biotechnology Products.

• Biotech With 45 new drug approvals in 2019, ‘friendly’ FDA is here to stay

  13 January 2020 Amirah Al Idrus / FiercePharma

  It looks like drug approvals have well and truly bounced back. 2019’s total of 45 approvals may not have hit the record high posted in 2018, but it fits into a general upward trend since 2016, when the FDA approved just 22 drugs.